CNA Financial Corporation And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – CNA Financial Corporation (CNA), DexCom (DXCM), Ryman Hospitality Properties (RHP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. CNA Financial Corporation (CNA)

48.2% sales growth and 9.2% return on equity

CNA Financial Corporation provides commercial property and casualty insurance products primarily in the United States. It operates through Specialty, Commercial, International, Life & Group, and Corporate & Other segments. The company offers professional liability coverages and risk management services to various professional firms, including architects, real estate agents, and accounting and law firms; directors and officers, employment practices, fiduciary, and fidelity coverages to small and mid-size firms, public and privately held firms, and not-for-profit organizations; professional and general liability, as well as associated standard property and casualty coverages for healthcare industry; surety and fidelity bonds; and warranty and alternative risks products. It also provides property insurance products, such as property, marine, boiler, and machinery coverages; casualty insurance products comprising workers' compensation, general and product liability, commercial auto, and umbrella coverages; specialized loss-sensitive insurance programs and total risk management services; and run-off long term care policies. In addition, the company offers long-tail exposures comprising commercial automobile liability, workers compensation, general and medical professional liability, other professional and management liability, and assumed reinsurance run-off and products liability; and short-tail exposures, such as property, commercial automobile physical damage, marine, surety, and warranty. It markets its products through independent agents, brokers, and general underwriters to small, medium, and large businesses; insurance companies; associations; professionals; and other groups in the marine, oil and gas, construction, manufacturing, life science, property, financial services, healthcare, and technology industries. The company was founded in 1853 and is headquartered in Chicago, Illinois. CNA Financial Corporation operates as a subsidiary of Loews Corporation.

Earnings Per Share

As for profitability, CNA Financial Corporation has a trailing twelve months EPS of $3.29.

PE Ratio

CNA Financial Corporation has a trailing twelve months price to earnings ratio of 12.14. Meaning, the purchaser of the share is investing $12.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.2%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 30% and 28.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 12.15B for the twelve trailing months.

Yearly Top and Bottom Value

CNA Financial Corporation’s stock is valued at $39.94 at 20:22 EST, way below its 52-week high of $45.42 and way above its 52-week low of $35.90.

2. DexCom (DXCM)

22.1% sales growth and 16.41% return on equity

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, DexCom has a trailing twelve months EPS of $0.72.

PE Ratio

DexCom has a trailing twelve months price to earnings ratio of 154.53. Meaning, the purchaser of the share is investing $154.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.41%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

DexCom’s EBITDA is 13.47.

Moving Average

DexCom’s value is way below its 50-day moving average of $126.34 and below its 200-day moving average of $117.44.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 17.9% and 11.8%, respectively.

Yearly Top and Bottom Value

DexCom’s stock is valued at $111.26 at 20:22 EST, way under its 52-week high of $139.55 and way above its 52-week low of $78.94.

Previous days news about DexCom(DXCM)

  • According to Zacks on Monday, 14 August, "Some better-ranked stocks in the broader medical space are Haemonetics (HAE Quick QuoteHAE – Free Report) , DexCom (DXCM Quick QuoteDXCM – Free Report) and Intuitive Surgical (ISRG Quick QuoteISRG – Free Report) . ", "Haemonetics sports a Zacks Rank #1 (Strong Buy), while DexCom and Intuitive Surgical carry a Zacks Rank #2 (Buy) each. "
  • According to Zacks on Tuesday, 15 August, "Another stock in the Medical sector, DexCom (DXCM Quick QuoteDXCM – Free Report) , has outperformed the sector so far this year. ", "Caribou Biosciences, Inc. and DexCom could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks."

3. Ryman Hospitality Properties (RHP)

13.5% sales growth and 115.31% return on equity

Ryman Hospitality Properties, Inc. (NYSE: RHP) is a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. The Company's core holdings* include a network of five of the top 10 largest non-gaming convention center hotels in the United States based on total indoor meeting space. These convention center resorts operate under the Gaylord Hotels brand and are managed by Marriott International. The Company also owns two adjacent ancillary hotels and a small number of attractions managed by Marriott International for a combined total of 10,110 rooms and more than 2.7 million square feet of total indoor and outdoor meeting space in top convention and leisure destinations across the country. The Company's Entertainment segment includes a growing collection of iconic and emerging country music brands, including the Grand Ole Opry; Ryman Auditorium, WSM 650 AM; Ole Red and Circle, a country lifestyle media network the Company owns in a joint-venture with Gray Television. The Company operates its Entertainment segment as part of a taxable REIT subsidiary. * The Company is the sole owner of Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; and Gaylord National Resort & Convention Center. It is the majority owner and managing member of the joint venture that owns the Gaylord Rockies Resort & Convention Center.

Earnings Per Share

As for profitability, Ryman Hospitality Properties has a trailing twelve months EPS of $3.82.

PE Ratio

Ryman Hospitality Properties has a trailing twelve months price to earnings ratio of 24.95. Meaning, the purchaser of the share is investing $24.95 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 115.31%.

Sales Growth

Ryman Hospitality Properties’s sales growth is 8.7% for the ongoing quarter and 13.5% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 4.3%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 35.2% and 5.1%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 64.9%, now sitting on 1.99B for the twelve trailing months.

4. K12 (LRN)

9% sales growth and 13.28% return on equity

K12 Inc., a technology-based education company, provides proprietary and third-party online curriculum, software systems, and educational services to facilitate individualized learning for students primarily in kindergarten through 12th grade (K-12) in the United States and internationally. The company offers managed public school programs, which offer an integrated package of systems, services, products, and professional services that K12 administers to support an online or blended public school, including administrative support, information technology and provisioning, academic support, curriculum, learning systems, and instructional services. It also provides institutional–non-managed public school programs, which offers instruction, curriculum, supplemental courses, marketing, enrollment, and other educational services; and institutional software and services, such as educational software and services to school districts, public schools, and other educational institutions. In addition, the company offers private pay schools and other services; and talent development services for individuals and enterprises in information technology fields. Further, it provides curriculum portfolios, pre-K and K-8 courses, high school courses, learning applications, and learning management systems; and TotalView, a student information system, which include a suite of online applications that offers administrators, teachers, parents, and students a view of student attendance, truancy management, graduation planning, communications, and learning kit shipment tracking. Additionally, the company provides a suite of services, such as academic support, and administrative and technology to students and their families, as well as directly to virtual and blended public schools, traditional schools, and school districts. It sells individual K-8 online courses and supplemental educational products directly to families. K12 Inc. was founded in 2000 and is headquartered in Herndon, Virginia.

Earnings Per Share

As for profitability, K12 has a trailing twelve months EPS of $2.54.

PE Ratio

K12 has a trailing twelve months price to earnings ratio of 15.21. Meaning, the purchaser of the share is investing $15.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.

Sales Growth

K12’s sales growth is 1.2% for the current quarter and 9% for the next.

5. PayPal (PYPL)

8.1% sales growth and 20.67% return on equity

PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. The company provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, PayPal Zettle, Hyperwallet, PayPal Honey, and Paidy names. Its payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 150 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. The company was founded in 1998 and is headquartered in San Jose, California.

Earnings Per Share

As for profitability, PayPal has a trailing twelve months EPS of $2.32.

PE Ratio

PayPal has a trailing twelve months price to earnings ratio of 26.63. Meaning, the purchaser of the share is investing $26.63 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.67%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 13.9% and 12.9%, respectively.

Yearly Top and Bottom Value

PayPal’s stock is valued at $61.78 at 20:22 EST, way below its 52-week high of $103.03 and above its 52-week low of $58.95.

Previous days news about PayPal(PYPL)

  • PayPal taps intuit executive as CEO. According to MarketWatch on Monday, 14 August, "First and foremost, PayPal will need to change the Apple Pay share-loss narrative," Dolev said in a note to clients. ", "Intuit Inc. executive Alex Chriss will serve as the next leader of PayPal Holdings Inc., the digital payments giant said Monday."
  • According to Zacks on Monday, 14 August, "The integration of payment options such as Venmo and PayPal has further enriched the overall customer experience."

Leave a Reply

Your email address will not be published. Required fields are marked *